Cost-effectiveness of camrelizumab combined with chemotherapy in the first-line treatment of recurrent or metastatic nasopharyngeal carcinoma in ChinaZiying Zhao, Tongfeng Chen, Zhen Zhou, Rui Guo, Qiao Liu
18 December 2023
First-line treatment with durvalumab plus chemotherapy versus chemotherapy alone for metastatic non-small-cell lung cancer in the USA: a cost-effectiveness analysisZhiwei Zheng, Ling Fang, Hongfu Cai
14 December 2023
Cost-effectiveness of Spironolactone for Adult Female Acne (SAFA): economic evaluation alongside a randomised controlled trialSarah Pyne, Tracey H Sach, Megan Lawrence, Susanne Renz, Zina Eminton, Beth Stuart, Kim S Thomas, Nick Francis, Irene Soulsby, Karen Thomas, Natalia V Permyakova, Matthew J Ridd, Paul Little, Ingrid Muller, Jacqui NuttallSee the full list of authors
11 December 2023
mHealth application for improving treatment outcomes for patients with multidrug-resistant tuberculosis in Vietnam: an economic evaluation protocol for the V-SMART trialQinglu Cheng, Tho Dang, Thu-Anh Nguyen, Kavindhran Velen, Viet Nhung Nguyen, Binh Hoa Nguyen, Dinh Hoa Vu, Chuong Huynh Long, Thu Thuong Do, Truong-Minh Vu, Guy B Marks, Manisha Yapa, Gregory J Fox, Virginia Wiseman
11 December 2023
Cost-effectiveness analysis of probiotic peanut oral immunotherapy (PPOIT) versus placebo in Australian children with peanut allergy alongside a randomised trialLi Huang, Kim Dalziel, Melanie Lloyd, Paxton Loke, Adriana C Lozinsky, Mimi Tang
10 December 2023
Measuring the success of programmes of care for people living with dementia: a protocol for consensus building with consumers to develop a set of Core Outcome Measures for Improving Care (COM-IC)Tracy Comans, Kim Nguyen, Len Gray, Leon Flicker, Paula Williamson, Susanna Dodd, Anna Kearney, Colm Cunningham, Thomas Morris, Jack Nunn, Dominic Trepel, Osvaldo P Almeida, Danelle Kenny, Alyssa Welch, Judy A LowthianSee the full list of authors
10 December 2023
Economic evaluation of serplulimab plus chemotherapy as the first-line treatment of oesophageal squamous cell carcinoma in ChinaFang Chen, Yunchun Long, Jiayong Yang, Kailong Zhong, Bili Liu
7 December 2023
Estimating the cost and epidemiology of mild to severe chronic pain associated with osteoarthritis in England: a retrospective analysis of linked primary and secondary care dataChristoph Lohan, Greg Coates, Peter Clewes, Hannah Stevenson, Robert Wood, Theo Tritton, Lucy Massey, Roger Knaggs, Alastair J Dickson, David Walsh
29 November 2023
Cost-effectiveness of providing university students with a mindfulness-based intervention to reduce psychological distress: economic evaluation of a pragmatic randomised controlled trialAdam P Wagner, Julieta Galante, Géraldine Dufour, Garry Barton, Jan Stochl, Maris Vainre, Peter B Jones
23 November 2023
Early offering transcatheter aortic valve replacement to patients with moderate aortic stenosis: quantifying costs and benefits – a Markov model-based simulation studyDieu Nguyen, Tom Marwick, Marj Moodie, Lan Gao
22 November 2023
